Citation: Mm. Ohayon et al., PREVALENCE OF NIGHTMARES AND THEIR RELATIONSHIP TO PSYCHOPATHOLOGY AND DAYTIME FUNCTIONING IN INSOMNIA SUBJECTS, Sleep, 20(5), 1997, pp. 340-348
Citation: D. Garrigougadenne et al., INFLUENCE OF THE RATE OF INTRAVENOUS ADMINISTRATION OF ELIPRODIL (SL-82.0715), A NEW ANTIISCHEMIC AGENT, ON ITS DISTRIBUTION IN RAT PLASMA AND TISSUES, Journal of pharmacokinetics and biopharmaceutics, 23(2), 1995, pp. 147-161
Authors:
PATAT A
TROCHERIE S
THEBAULT JJ
ROSENZWEIG P
DUBRUC C
BIANCHETTI G
MORSELLI PL
COURT LA
Citation: A. Patat et al., EEG PROFILE OF LITOXETINE AFTER SINGLE AND REPEATED ADMINISTRATION INHEALTHY-VOLUNTEERS, British journal of clinical pharmacology, 37(2), 1994, pp. 157-163
Authors:
MONTI JM
ATTALI P
MONTI D
ZIPFEL A
DELAGICLAIS B
MORSELLI PL
Citation: Jm. Monti et al., ZOLPIDEM AND REBOUND INSOMNIA - A DOUBLE-BLIND, CONTROLLED POLYSOMNOGRAPHIC STUDY IN CHRONIC INSOMNIAC PATIENTS, Pharmacopsychiatry, 27(4), 1994, pp. 166-175
Authors:
AARONS L
BALANT LP
MENTRE F
MORSELLI PL
ROWLAND M
STEIMER JL
VOZEH S
Citation: L. Aarons et al., POPULATION APPROACHES IN DRUG DEVELOPMENT - REPORT ON AN EXPERT MEETING TO DISCUSS POPULATION PHARMACOKINETIC PHARMACODYNAMIC SOFTWARE/, European Journal of Clinical Pharmacology, 46(5), 1994, pp. 389-391
Authors:
FRATTOLA L
GARREAU M
PIOLTI R
BASSI S
ALBIZZATI MG
BORGHI C
MORSELLI PL
Citation: L. Frattola et al., COMPARISON OF THE EFFICACY, SAFETY AND WITHDRAWAL OF ALPIDEM AND ALPRAZOLAM IN ANXIOUS PATIENTS, British Journal of Psychiatry, 165, 1994, pp. 94-100
Authors:
ROSENZWEIG P
WARRINGTON S
PATAT A
ASCALONE V
BERGOUGNAN L
MORSELLI PL
Citation: P. Rosenzweig et al., ALPIDEM - LACK OF SEDATIVE EFFECT ON PSYCHOMOTOR PERFORMANCE IN THERAPEUTIC DOSES, Human psychopharmacology, 8(6), 1993, pp. 409-415
Authors:
BALANT LP
ROWLAND M
AARONS L
MENTRE F
MORSELLI PL
STEIMER JL
VOZEH S
Citation: Lp. Balant et al., NEW STRATEGIES IN DRUG DEVELOPMENT AND CLINICAL-EVALUATION - THE POPULATION APPROACH - COMMENTARY ON AN ACTION FOR COOPERATIVE RESEARCH, European Journal of Clinical Pharmacology, 45(2), 1993, pp. 93-94